Insight: FDA warned PIP on breast implant safety
cure is worse than the disease
Plastic surgeon Denis Boucq displays a silicone gel breast implant manufactured by French company Poly Implant Prothese (PIP) in a clinic in Nice December 26, 2011.
WASHINGTON (Reuters) - As early as 2000, U.S. health authorities raised concerns about the French breast implant maker at the heart of a scandal affecting hundreds of thousands of women worldwide. That was almost ten years before the company came under scrutiny from European regulators.
Credit: Reuters/Eric Gaillard
Anna Yukhananov
WASHINGTON
Tue Dec 27, 2011 5:12am EST
link-
http://www.reuters.com/article/2011/12/27/us-breastimplants-fda-idUSTRE7BQ03M20111227